Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 22 min 37 sec ago

Thoratec Receives CE Mark Approval For HeartMate PHP(TM)

Mon, 07/13/2015 - 15:40
PLEASANTON, Calif., July 13, 2015 -- (Healthcare Sales & Marketing Network) -- Thoratec Corporation (THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced that HeartMate PHP (Percutaneous ...
Devices, Cardiology, Regulatory
Thoratec, HeartMate, Percutaneous Heart Pump, cardiac assist device

RIVANNA Has Received FDA Clearance of Its Accuro(TM) Device

Mon, 07/13/2015 - 15:37
Accuro(TM) provides untethered ultrasound imaging to automatically guide spinal anesthesia with additional indications for ultrasound imaging of abdominal, musculoskeletal, cardiac, and peripheral vascular anatomies CHARLOTTESVILLE, Va.--(Healthcare Sal...
Devices, FDA
Rivanna Medical, imaging, ultrasound, spinal anesthesia

Accuray and RaySearch Announce Long-Term Collaboration Agreement Regarding the RayCare(R) Oncology Information System

Mon, 07/13/2015 - 14:40
SUNNYVALE, Calif. & STOCKHOLM--(Healthcare Sales & Marketing Network)--Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today they have signed a long-term collaboration agreement which will al...
Devices, Oncology
RaySearch Laboratories, Accuray, radiotherapy, TomoTherapy, CyberKnife

Leading European Health Centers to Improve Cranial Radiosurgery with Elekta's new Leksell Gamma Knife Icon

Mon, 07/13/2015 - 14:28
STOCKHOLM, July 13, 2015 -- (Healthcare Sales & Marketing Network) -- Three foremost medical centers in the United Kingdom and Germany have ordered and are now planning upgrades to Elekta's latest generation stereotactic radiosurgery system for the brain,...
Devices, Oncology, Neurosurgery
Elekta, radiosurgery, Gamma Knife, radiotherapy

In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People With a Specific Type of Bladder Cancer

Mon, 07/13/2015 - 14:18
Results showed that high levels of PD-L1 expression were associated with greater responses to atezolizumab Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of atezolizumab’s Breakthrough Therapy Designation in blad...
Biopharmaceuticals, Oncology, Urology
Genentech, Roche Group, atezolizumab, bladder cancer

Brickell Biotech Announces Appointment of Industry Veteran Patricia Walker, MD, PhD as President and Chief Scientific Officer

Fri, 07/10/2015 - 16:35
Elizabeth Hussey, Pharm.D, Joins as Vice President, Product Development MIAMI--(Healthcare Sales & Marketing Network)--Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative ...
Biopharmaceuticals, Personnel
Brickell Biotech

Sorin Group Announces Global Launch of Its Latest Generation of Heating and Cooling Systems at FECECT 2015

Fri, 07/10/2015 - 13:19
FlexThermTM, the newest addition to Sorin Heartlink System, is fully integrated with Sorin S5 industry-leading heart-lung machine MILAN--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), (Reuters Code: SORN.MI), a global medical company an...
Devices, Cardiology, Product Launch
Sorin Group, FlexTherm, Extracorporeal Circulation

BioStar Ventures Raises $68.8 Million for Third Fund

Thu, 07/09/2015 - 16:00
PETOSKEY, Mich.--(Healthcare Sales & Marketing Network)--BioStar Ventures, a strategic venture capital partnership focused on accelerating value creation for medical device and connected health technologies in cardiovascular and orthopedic medicine, today ...
Devices, Cardiology, Orthopaedic, Venture Capital
BioStar Ventures

BioStar Ventures Raises $68.8 Million for Third Fund

Thu, 07/09/2015 - 16:00
PETOSKEY, Mich.--(Healthcare Sales & Marketing Network)--BioStar Ventures, a strategic venture capital partnership focused on accelerating value creation for medical device and connected health technologies in cardiovascular and orthopedic medicine, today ...
Devices, Cardiology, Orthopaedic, Venture Capital
BioStar Ventures

Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience

Thu, 07/09/2015 - 15:55
DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Baxalta Incorporated (BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announces the appointment ...
Biopharmaceuticals, Personnel

Boston Scientific Bronchial Thermoplasty Treatment Recognized By American College Of Allergy, Asthma And Immunology

Thu, 07/09/2015 - 14:28
MARLBOROUGH, Mass., July 9, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) announces that Bronchial Thermoplasty (BT) delivered by the Alair™ System has received support from the American College of Allergy, Asthma a...
Boston Scientific, Bronchial Thermoplasty, Alair System, asthma

The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)

Thu, 07/09/2015 - 14:20
PARSIPPANY, N.J.--(Healthcare Sales & Marketing Network)--The Medicines Company (MDCO) today announced an agreement with Sandoz Inc. for the distribution of an authorized generic of ANGIOMAX® (bivalirudin) for injection in the United States. “Bivali...
Biopharmaceuticals, Generics, Product Launch
The Medicines Company, Sandoz, ANGIOMAX, bivalirudin, anti-thrombin

OBP Medical Launches CLEAR-TRAC Family of Novel, All-in-One Surgical Retractors

Wed, 07/08/2015 - 16:18
Innovative single-use retractors with built-in LED light source deliver cost-effective solution while maximizing clinical functionality and reducing cross-contamination risk LAWRENCE, Mass., July 8, 2015 -- (Healthcare Sales & Marketing Network) -- OBP...
Devices, Surgery, Product Launch
OBP Medical, CLEAR-TRAC, retractor

Takatsuki General Hospital Performs First Procedure With Stereotaxis Niobe(R) ES Technology in Japan

Wed, 07/08/2015 - 15:49
ST. LOUIS, July 8, 2015 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that the first procedure with its Niobe(R) ES magnetic navig...
Devices, Cardiology
Stereotaxis, Niobe ES, Niobe, cardiac ablation, navigation system

GTx Appoints Diane Young, M.D. as Vice President, Chief Medical Officer

Wed, 07/08/2015 - 15:43
Pharmaceutical veteran adds depth and experience to executive team MEMPHIS, Tenn.--(Healthcare Sales & Marketing Network)--GTx, Inc. (GTXI) today announced the appointment of Diane C. Young, M.D., as Vice President, Chief Medical Officer. Dr. Young is a...
Biopharmaceuticals, Oncology, Personnel

Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer

Wed, 07/08/2015 - 15:34
NEW YORK--(Healthcare Sales & Marketing Network)--Synergy Pharmaceuticals Inc. (SGYP) today announced that Troy Hamilton has joined the company as Chief Commercial Officer. Mr. Hamilton will be responsible for Synergy’s overall commercial strategy and exec...
Biopharmaceuticals, Personnel
Synergy Pharmaceuticals, plecanatide

Safe Orthopaedics Announces the Release of the Auto-Adjust Pedicle Screw System for Repairing Traumatic Spine Injuries

Wed, 07/08/2015 - 13:08
First patients treated in Europe at leading spine centers Novel, patented system, designed to facilitate restoration of the natural spinal balance Factory pre-packaged implants and single-use instruments designed for enhanced patient safety and ‘on-t...
Devices, Neurosurgery, Orthopaedic, Product Launch
Safe Orthopaedics, Auto-Adjust pedicle screw, pedicle screw, spine surgery

Diadexus, Inc. Names William Hammond as Vice President of Sales

Tue, 07/07/2015 - 15:19
SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced that William Harrison Hammond ...
Diagnostics, Cardiology, Personnel
Diadexus, Lp-PLA2

Theranos Receives First FDA Clearance for Finger Stick and Venous Blood Test and Independent FDA Review and Validation of its Underlying Theranos System for Herpes Simplex Virus-1 Diagnosis

Tue, 07/07/2015 - 15:13
Major milestone for Theranos and national preventive health care landscape PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--Theranos, Inc. (Theranos) today announced that it has received the U.S. Food and Drug Administration’s (FDA) clearance ...
Diagnostics, FDA
Theranos , Laboratory Developed Test, HSV

Cynosure Receives Expanded FDA 510(k) Clearance To Market SculpSure(TM) for Non-Invasive Lipolysis of the Abdomen

Tue, 07/07/2015 - 14:05
Company's Newest Flagship Product Now Cleared for Treatment of Two Troublesome Body Areas WESTFORD, Mass., July 7, 2015 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO), a leader in laser- and light-based aesthetic treatments, today ...
Devices, FDA, Dermatology
Cynosure, SculpSure, lipolysis

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong